-
-
UAB researchers aim to improve sleep and quality of life for individuals with Down syndromeSep 06, 2024For their continued research in sleep disorders in individuals with Down syndrome, UAB’s Caroline G. Richter, Ph.D. and S. Justin Thomas, Ph.D. were named the recipients of the 2024-2025 McNulty Civitan Scientist Award.
-
Research in the classroom: Students conduct precision medicine research that benefits patients with neurological diseases through Undergraduate Neurosciences Program coursesSep 04, 2024Camerron Crowder, Ph.D., assistant professor in the UAB Department of Neurobiology and assistant director of the Hugh Kaul Precision Medicine Institute (PMI), offers a unique research opportunity for undergraduate students by teaching the PMI research process, how to develop animal models, and the use of artificial intelligence to identify treatment options through courses in the Undergraduate Neuroscience Program.
-
Cummings discovers unexpected role of brain region in fear processing, highlighting new PTSD treatment targetAug 28, 2024Kirstie Cummings, Ph.D., an assistant professor in the Department of Neurobiology, was recently honored with the Heersink School of Medicine's Featured Discovery Award. She was recognized alongside Zephyr R. Desa, a UAB neuroscience Ph.D. student, and Rodrigo Campos-Cardoso, Ph.D., a UAB postdoc, the study’s first authors. The initiative highlights significant research contributions from Heersink faculty members.
-
-
-
-
Newsom completes Phase 2 clinical trial of a novel drug for Pitt-Hopkins SyndromeJun 28, 2024Cassandra Newsom, Psy.D., director of the Translational Research Core in Autism and Neurodevelopment of Civitan International Research Center, has completed participation in Phase 2 Clinical Trials of a new drug, NNZ-2591, that shows promising results for a devastating neurodevelopmental disorder called Pitt-Hopkins Syndrome (PTHS).
-
-